- KALCIKINON a measure that favorably affects bone health. It strengthens bones and reduces the permeability of blood vessel walls. Regulates muscle tissue. Responsible for the proper distribution of calcium into the tissue.
KALCIKINON osteoporosis treatment Composition:
calcium carbonate, anti-caking agent microcrystalline cellulose, KINON1 (menaquinone-7 - vitamin K obtained from the fermentation of soy), stabilizers; cross-linked sodium carboxymethylcellulose and poliwinyiopirolidon, anti-caking agents: vegetable magnesium stearate, and stearic acid, cholecalciferol (vitamin D3), anti-caking agent silicon dioxide.
|Nutritional value||2 tablets||100 g|
|carbohydrates||0.18 g||11.1 g|
|Fat||0 g||0 g|
|Calcium||500 mg (62.5% RDA *)||31250 mg (3906% RDA *)|
|Vitamin K2||75 mcg (100% RDA *)||4687.5 mcg (6250% RDA *)|
|Vitamin D3||25 mcg (500% RDA *)||1562.5 mcg (31250% RDA *)|
* RDA - recommended daily allowance
The center for special medical purposes complements the body's levels of calcium and vitamin D3. As a result, it strengthens bone tissue and reduces the permeability of blood vessel walls. Reduces the permeability of blood vessels, and thus has anti-edema, anti-inflammatory and antiallergic. Participates in the conduction of nerve and muscle contractility. Regulates calcium and phosphate levels, and increases the calcium absorption from the gastrointestinal tract, and it contributes to proper distribution of the component tissues.
- Hypersensitivity to the preparation ingredients
Indications: The preparation is recommended to be taken in case of osteoporosis, osteomalacia, bone fractures and intensive growth.
For oral use. It is recommended that 2 tabl./24h while eating.